Polycystic ovary syndrome.
Conditions
Interventions
Intervention 1: Intervention group: People participating in the study are randomly divided into two groups A and B with equal sample size.For group A, from the third to the seventh day of the menstrua
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Female gender Infertile who have not had a history of pregnancy after 12 months of unprotected intercourse Suffering from polycystic ovary syndrome At least 40 years old
Exclusion criteria
Exclusion criteria: Non-consent to participate in the study drug sensitivity to letrozole or tamoxifen or estradiol or vitamin E the existence of any other pathology that has led to infertility in the patient or his wife liver or kidney dysfunction diabetes mellitus type one or two Thyroid disordes congenital adrenal hyperplasia abnormal hysterosalpingography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy. Timepoint: One day after the fall in menstruation. Method of measurement: ß-HCG titer test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Follicle size, follicle number and follicle thickness. Timepoint: Days 3, 7 and 12 of the cycle. Method of measurement: sonography.;Multiple births. Timepoint: Week 6 of pregnancy. Method of measurement: sonography.;Drug side effects. Timepoint: The total time of the intervention. Method of measurement: Examination by the doctor and self-reported by the patient based on previous training. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactathar raskh
Jahrom University of Medical Sciences
Outcome results
None listed